Company · Toronto, Ontario, Canada
Janssen Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 260
- 121 authorized now
- Natural health products
- 3
- 0 active licences
- Medical device licences
- 2
- 0 active
- Notices of Compliance
- 441
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| AKEEGA | 02538555 | Marketed | |
| AKEEGA | 02538563 | Marketed | |
| BALVERSA | 02493217 | Marketed | |
| BALVERSA | 02493225 | Marketed | |
| BALVERSA | 02493233 | Marketed | |
| CARIPUL | 02397447 | Marketed | |
| CARIPUL | 02397455 | Marketed | |
| CONCERTA | 02247732 | Marketed | |
| CONCERTA | 02247733 | Marketed | |
| CONCERTA | 02247734 | Marketed | |
| CONCERTA | 02250241 | Marketed | |
| DARZALEX | 02455951 | Marketed | |
| DARZALEX | 02455978 | Marketed | |
| DARZALEX SC | 02502712 | Marketed | |
| EDURANT | 02370603 | Marketed | |
| ELMIRON | 02029448 | Marketed | |
| EPREX STERILE SOLUTION | 02243239 | Marketed | |
| EPREX STERILE SOLUTION | 02288680 | Marketed | |
| EPREX STERILE SOLUTION 10000IU/1.0ML | 02231587 | Marketed | |
| EPREX STERILE SOLUTION 1000IU/0.5ML | 02231583 | Marketed | |
| EPREX STERILE SOLUTION 2000IU/0.5ML | 02231584 | Marketed | |
| EPREX STERILE SOLUTION 3000IU/0.3ML | 02231585 | Marketed | |
| EPREX STERILE SOLUTION 40000IU/ML | 02240722 | Marketed | |
| EPREX STERILE SOLUTION 4000IU/0.4ML | 02231586 | Marketed | |
| EPREX STERILE SOLUTION 5000IU/0.5ML | 02243400 | Marketed | |
| EPREX STERILE SOLUTION 6000 IU/0.6 ML | 02243401 | Marketed | |
| EPREX STERILE SOLUTION 8000 IU/0.8 ML | 02243403 | Marketed | |
| ERLEADA | 02478374 | Marketed | |
| ERLEADA | 02540185 | Marketed | |
| FINLIUS | 02537257 | Marketed | |
| FINLIUS | 02537303 | Marketed | |
| FINLIUS I.V. | 02537311 | Marketed | |
| IMAAVY | 02563509 | Marketed | |
| IMAAVY | 02563517 | Marketed | |
| IMBRUVICA | 02434407 | Marketed | |
| IMBRUVICA | 02540215 | Marketed | |
| INTELENCE | 02306778 | Marketed | |
| INTELENCE | 02375931 | Marketed | |
| INVEGA | 02300273 | Marketed | |
| INVEGA | 02300281 | Marketed | |
| INVEGA | 02300303 | Marketed | |
| INVEGA SUSTENNA | 02354217 | Marketed | |
| INVEGA SUSTENNA | 02354225 | Marketed | |
| INVEGA SUSTENNA | 02354233 | Marketed | |
| INVEGA SUSTENNA | 02354241 | Marketed | |
| INVEGA TRINZA | 02455943 | Marketed | |
| INVEGA TRINZA | 02455986 | Marketed | |
| INVEGA TRINZA | 02455994 | Marketed | |
| INVEGA TRINZA | 02456001 | Marketed | |
| INVOKAMET | 02455404 | Marketed | |
| INVOKAMET | 02455420 | Marketed | |
| INVOKAMET | 02455455 | Marketed | |
| INVOKANA | 02425483 | Marketed | |
| INVOKANA | 02425491 | Marketed | |
| LAZCLUZE | 02555964 | Marketed | |
| LAZCLUZE | 02555972 | Marketed | |
| OPSUMIT | 02415690 | Marketed | |
| OPSUMIT | 02561069 | Marketed | |
| OPSYNVI | 02521083 | Marketed | |
| PARIET, ENTERIC-COATED TABLET 10MG | 02243796 | Marketed | |
| PARIET, ENTERIC-COATED TABLET 20MG | 02243797 | Marketed | |
| PREZCOBIX | 02426501 | Marketed | |
| REMICADE | 02244016 | Marketed | |
| RISPERDAL CONSTA | 02255707 | Marketed | |
| RISPERDAL CONSTA | 02255723 | Marketed | |
| RISPERDAL CONSTA | 02255758 | Marketed | |
| RISPERDAL CONSTA | 02298465 | Marketed | |
| RYBREVANT | 02526182 | Marketed | |
| RYBREVANT SC | 02569140 | Marketed | |
| RYBREVANT SC | 02569159 | Marketed | |
| RYBREVANT SC | 02569167 | Marketed | |
| RYBREVANT SC | 02569175 | Marketed | |
| SIMPONI | 02324776 | Marketed | |
| SIMPONI | 02324784 | Marketed | |
| SIMPONI | 02413175 | Marketed | |
| SIMPONI | 02413183 | Marketed | |
| SIMPONI I.V. | 02417472 | Marketed | |
| SPRAVATO | 02499290 | Marketed | |
| STELARA | 02320673 | Marketed | |
| STELARA | 02320681 | Marketed | |
| STELARA I.V. | 02459671 | Marketed | |
| SYMTUZA | 02473720 | Marketed | |
| TALVEY | 02547392 | Marketed | |
| TALVEY | 02547406 | Marketed | |
| TECVAYLI | 02539756 | Marketed | |
| TECVAYLI | 02539764 | Marketed | |
| TOPAMAX | 02239907 | Marketed | |
| TOPAMAX | 02239908 | Marketed | |
| TRACLEER | 02244981 | Marketed | |
| TRACLEER | 02244982 | Marketed | |
| TREMFYA | 02469758 | Marketed | |
| TREMFYA | 02559145 | Marketed | |
| TREMFYA | 02566877 | Marketed | |
| TREMFYA I.V. | 02559153 | Marketed | |
| TREMFYA ONE-PRESS | 02487314 | Marketed | |
| UPTRAVI | 02451158 | Marketed | |
| UPTRAVI | 02451166 | Marketed | |
| UPTRAVI | 02451174 | Marketed | |
| UPTRAVI | 02451182 | Marketed | |
| UPTRAVI | 02451190 | Marketed | |
| UPTRAVI | 02451204 | Marketed | |
| UPTRAVI | 02451212 | Marketed | |
| UPTRAVI | 02451220 | Marketed | |
| VELCADE | 02262452 | Marketed | |
| VERMOX | 00556734 | Marketed | |
| ZAVESCA | 02250519 | Marketed | |
| ZYTIGA | 02371065 | Marketed | |
| ZYTIGA | 02457113 | Marketed | |
| BALVERSA | 02493241 | Approved | |
| CARVYKTI | 02535270 | Approved | |
| IMBRUVICA | 02486733 | Approved | |
| IMBRUVICA | 02486741 | Approved | |
| IMBRUVICA | 02486768 | Approved | |
| IMBRUVICA | 02486776 | Approved | |
| LIVMOTY | 02559536 | Approved | |
| LIVMOTY | 02559544 | Approved | |
| LIVMOTY | 02559552 | Approved | |
| LIVMOTY | 02559560 | Approved | |
| OMVYENCE | 02510308 | Approved | |
| TREMFYA | 02559137 | Approved | |
| TREMFYA | 02570890 | Approved | |
| ALFENTA INJ 500MCG/ML | 00755818 | Cancelled Post Market | |
| CLINACOX 0.5% PREMIX | 00888508 | Cancelled Post Market | |
| CYCLEN TABLETS (21 DAY) | 01968440 | Cancelled Post Market | |
| CYCLEN TABLETS (28 DAY) | 01992872 | Cancelled Post Market | |
| DITROPAN SYRUP 1MG/ML | 01924753 | Cancelled Post Market | |
| DITROPAN TABLETS 5MG | 01924761 | Cancelled Post Market | |
| DITROPAN XL | 02243960 | Cancelled Post Market | |
| DITROPAN XL | 02243961 | Cancelled Post Market | |
| DITROPAN XL | 02259117 | Cancelled Pre Market | |
| DORIBAX | 02332906 | Cancelled Post Market | |
| DURAGESIC | 02275813 | Cancelled Post Market | |
| DURAGESIC | 02275821 | Cancelled Post Market | |
| DURAGESIC | 02275848 | Cancelled Post Market | |
| DURAGESIC | 02275856 | Cancelled Post Market | |
| DURAGESIC | 02334186 | Cancelled Post Market | |
| DURAGESIC 100 | 01937413 | Cancelled Post Market | |
| DURAGESIC 12 | 02280345 | Cancelled Post Market | |
| DURAGESIC 25 | 01937383 | Cancelled Post Market | |
| DURAGESIC 50 | 01937391 | Cancelled Post Market | |
| DURAGESIC 75 | 01937405 | Cancelled Post Market | |
| DURALITH TAB 300MG | 00590665 | Cancelled Post Market | |
| EPREX STERILE SOLUTION 10000IU/ML | 02126591 | Cancelled Post Market | |
| EPREX STERILE SOLUTION 20000IU/ML | 02206072 | Cancelled Post Market | |
| EPREX STERILE SOLUTION 2000IU/ML | 02126575 | Cancelled Post Market | |
| EPREX STERILE SOLUTION 4000IU/ML | 02126583 | Cancelled Post Market | |
| ERGAMISOL TAB 50MG | 00846368 | Cancelled Post Market | |
| EVRA -(6/0.75) | 02246340 | Cancelled Post Market | |
| FLEXERIL -(10MG) | 00782742 | Cancelled Post Market | |
| FLOXIN TABLETS 200MG | 01968424 | Cancelled Post Market | |
| FLOXIN TABLETS 300MG | 01968416 | Cancelled Post Market | |
| FLOXIN TABLETS 400MG | 01968408 | Cancelled Post Market | |
| GALEXOS | 02416441 | Cancelled Post Market | |
| HALDOL LA INJ 100MG/ML | 00599093 | Cancelled Post Market | |
| HALDOL LA INJ 50MG/ML | 00599085 | Cancelled Post Market | |
| INNOVAR-VET INJ | 00755672 | Cancelled Post Market | |
| INTELENCE | 02396750 | Cancelled Post Market | |
| INVEGA | 02300311 | Cancelled Pre Market | |
| INVEGA SUSTENNA | 02354209 | Cancelled Pre Market | |
| INVOKAMET | 02455412 | Cancelled Post Market | |
| INVOKAMET | 02455439 | Cancelled Post Market | |
| INVOKAMET | 02455447 | Cancelled Post Market | |
| INVOKAMET XR | 02477394 | Cancelled Pre Market | |
| INVOKAMET XR | 02477408 | Cancelled Pre Market | |
| INVOKAMET XR | 02477416 | Cancelled Pre Market | |
| INVOKAMET XR | 02477424 | Cancelled Pre Market | |
| JCOVDEN | 02513153 | Cancelled Post Market | |
| JURNISTA | 02337266 | Cancelled Post Market | |
| JURNISTA | 02337274 | Cancelled Post Market | |
| JURNISTA | 02337282 | Cancelled Post Market | |
| JURNISTA | 02337290 | Cancelled Post Market | |
| LEUSTATIN 1MG/ML | 02022117 | Cancelled Post Market | |
| LEVAQUIN | 02236841 | Cancelled Post Market | |
| LEVAQUIN 25MG/ML | 02236840 | Cancelled Post Market | |
| LEVAQUIN 500MG | 02236842 | Cancelled Post Market | |
| LEVAQUIN 5MG/ML | 02236839 | Cancelled Post Market | |
| LEVAQUIN 750MG | 02246804 | Cancelled Post Market | |
| LEVASOLE POUR-ON LIQ 20% | 00710148 | Cancelled Post Market | |
| LEVASOLE SOLUTION INJ 136.5MG/ML | 00733105 | Cancelled Post Market | |
| LIVOSTIN SUS NAS 0.5MG/ML | 02020017 | Cancelled Post Market | |
| METOFANE ASP 99.99% | 02019027 | Cancelled Post Market | |
| MICRONOR TABLETS 28-DAY | 00037605 | Cancelled Post Market | |
| MOTILIUM TAB 10MG | 00855820 | Cancelled Post Market | |
| NATRECOR | 02301393 | Cancelled Post Market | |
| NUCYNTA CR | 02360373 | Cancelled Post Market | |
| NUCYNTA CR | 02360381 | Cancelled Post Market | |
| NUCYNTA CR | 02360403 | Cancelled Post Market | |
| NUCYNTA CR | 02360411 | Cancelled Post Market | |
| NUCYNTA CR | 02360438 | Cancelled Post Market | |
| ORTHO 0.5/35 TABLETS (21 DAY) | 00317047 | Cancelled Post Market | |
| ORTHO 0.5/35 TABLETS (28 DAY) | 00340731 | Cancelled Post Market | |
| ORTHO 1/35 TABLETS (21 DAY) | 00372846 | Cancelled Post Market | |
| ORTHO 1/35 TABLETS (28 DAY) | 00372838 | Cancelled Post Market | |
| ORTHO 10/11 TABLETS (21 DAY) | 00538590 | Cancelled Post Market | |
| ORTHO 10/11 TABLETS (28 DAY) | 00538582 | Cancelled Post Market | |
| ORTHO 7/7/7 TABLETS (21 DAY) | 00602957 | Cancelled Post Market | |
| ORTHO 7/7/7 TABLETS (28 DAY) | 00602965 | Cancelled Post Market | |
| ORTHO-CEPT TABLETS (21 DAY) | 02042541 | Cancelled Post Market | |
| ORTHO-CEPT TABLETS (28 DAY) | 02042533 | Cancelled Post Market | |
| ORTHO-NOVUM 1/50 TABLETS (21 DAY) | 00022608 | Cancelled Post Market | |
| ORTHO-NOVUM 1/50 TABLETS (28 DAY) | 00340758 | Cancelled Post Market | |
| ORTHOCLONE OKT 3 STERILE SOLUTION IV 1MG/ML | 02015978 | Cancelled Post Market | |
| PANCREASE CAPSULES | 02242374 | Cancelled Post Market | |
| POLYCITRA-K | 02163233 | Cancelled Post Market | |
| PREZISTA | 02284057 | Cancelled Post Market | |
| PREZISTA | 02324016 | Cancelled Post Market | |
| PREZISTA | 02324024 | Cancelled Post Market | |
| PREZISTA | 02338432 | Cancelled Post Market | |
| PREZISTA | 02369753 | Cancelled Post Market | |
| PREZISTA | 02393050 | Cancelled Post Market | |
| PREZISTA | 02416530 | Cancelled Post Market | |
| REGRANEX (BECAPLERMIN) 0.01% | 02239405 | Cancelled Post Market | |
| REMINYL -(12MG) | 02244300 | Cancelled Post Market | |
| REMINYL -(4MG) | 02244298 | Cancelled Post Market | |
| REMINYL -(8MG) | 02244299 | Cancelled Post Market | |
| REMINYL ER | 02266717 | Cancelled Post Market | |
| REMINYL ER | 02266725 | Cancelled Post Market | |
| REMINYL ER | 02266733 | Cancelled Post Market | |
| REOPRO | 02216973 | Cancelled Post Market | |
| RISPERDAL | 02025299 | Cancelled Post Market | |
| RISPERDAL | 02025280 | Cancelled Post Market | |
| RISPERDAL | 02025302 | Cancelled Post Market | |
| RISPERDAL | 02025310 | Cancelled Post Market | |
| RISPERDAL | 02230455 | Cancelled Post Market | |
| RISPERDAL | 02240551 | Cancelled Post Market | |
| RISPERDAL | 02240552 | Cancelled Post Market | |
| RISPERDAL M-TAB | 02247704 | Cancelled Post Market | |
| RISPERDAL M-TAB | 02247705 | Cancelled Post Market | |
| RISPERDAL M-TAB | 02247706 | Cancelled Post Market | |
| RISPERDAL M-TAB | 02268086 | Cancelled Post Market | |
| RISPERDAL M-TAB | 02268094 | Cancelled Post Market | |
| RISPERDAL ORAL SOLUTION | 02236950 | Cancelled Post Market | |
| SPORANOX | 02047454 | Cancelled Post Market | |
| SPORANOX | 02231347 | Cancelled Post Market | |
| SUFENTA INJ 50MCG/ML | 01951319 | Cancelled Post Market | |
| TELMIN B SYRINGE FORMULA | 00755796 | Cancelled Post Market | |
| TERAZOL 3 DUAL PAK | 02130874 | Cancelled Post Market | |
| TERAZOL 3 VAGINAL CREAM 0.8% | 01934155 | Cancelled Post Market | |
| TERAZOL 3 VAGINAL OVULES 80MG | 00894710 | Cancelled Post Market | |
| TERAZOL 7 VAGINAL CREAM 0.4% | 00894729 | Cancelled Post Market | |
| TOLECTIN TAB 600MG | 00632740 | Cancelled Post Market | |
| TOPAMAX | 02231385 | Cancelled Pre Market | |
| TOPAMAX | 02231386 | Cancelled Pre Market | |
| TOPAMAX | 02231387 | Cancelled Pre Market | |
| TOPAMAX 100MG | 02230894 | Cancelled Post Market | |
| TOPAMAX 200MG | 02230896 | Cancelled Post Market | |
| TOPAMAX 25MG | 02230893 | Cancelled Post Market | |
| TRAMACET | 02264846 | Cancelled Post Market | |
| TRI-CYCLEN LO (21 DAY) | 02258560 | Cancelled Post Market | |
| TRI-CYCLEN LO (28 DAY) | 02258587 | Cancelled Post Market | |
| TRI-CYCLEN TABLETS - 21-DAY | 02028700 | Cancelled Post Market | |
| TRI-CYCLEN TABLETS - 28-DAY | 02029421 | Cancelled Post Market | |
| TYLENOL WITH CODEINE ELIXIR | 02163942 | Cancelled Post Market | |
| TYLENOL WITH CODEINE NO. 2 - TAB | 02163934 | Cancelled Post Market | |
| TYLENOL WITH CODEINE NO. 3 - TAB | 02163926 | Cancelled Post Market | |
| TYLENOL WITH CODEINE NO. 4 | 02163918 | Cancelled Post Market | |
| ULTRAM | 02349469 | Cancelled Post Market | |
| VETROPOLYCIN HC ONT | 02019299 | Cancelled Post Market | |
| VETROPOLYCIN ONT | 02019302 | Cancelled Post Market | |
| ZEFTERA | 02313103 | Cancelled Post Market |
Natural health products
Active licences first, newest first.
| Name | NPN | Status | Licensed |
|---|---|---|---|
| Pancrease MT 10 | 00789437 | Discontinued | |
| Pancrease MT 16 | 00789429 | Discontinued | |
| Pancrease MT4 | 00789445 | Discontinued |
Medical device licences
Active licences first, newest first.
| Name | Licence | Status | First licensed |
|---|---|---|---|
| REMIPACK | 73576 | Cancelled · Class 2 | |
| GYNE-T INTRAUTEERINE COPPER CONTRACEPTIVE | 13365 | Discontinued at renewal · Class 3 |
Notices of Compliance
Newest first.
- CARVYKTIOctober 9, 2026 · NOC 38450 · Supplement to a New Drug Submission (SNDS)
- DARZALEX SCOctober 2, 2026 · NOC 38408 · Supplement to a New Drug Submission (SNDS)
- RYBREVANTAugust 27, 2026 · NOC 38186 · Supplement to a New Drug Submission (SNDS)
- LAZCLUZEAugust 18, 2026 · NOC 38134 · Supplement to a New Drug Submission (SNDS)
- TREMFYA; TREMFYA ONE-PRESSAugust 14, 2026 · NOC 38113 · Supplement to a New Drug Submission (SNDS)
- IMAAVYAugust 13, 2026 · NOC 38105 · Supplement to a New Drug Submission (SNDS)
- ERLEADAAugust 5, 2026 · NOC 38057 · Supplement to a New Drug Submission (SNDS)
- TECVAYLIJuly 31, 2026 · NOC 38031 · Supplement to a New Drug Submission (SNDS)
- ERLEADAJuly 22, 2026 · NOC 37956 · Supplement to a New Drug Submission (SNDS)
- DARZALEX; DARZALEX SCJuly 2, 2026 · NOC 37825 · Supplement to a New Drug Submission (SNDS)
- SPORANOXJuly 2, 2026 · NOC 37826 · Supplement to a New Drug Submission (SNDS)
- INVEGA SUSTENNAJune 25, 2026 · NOC 37786 · Supplement to a New Drug Submission (SNDS)
- AKEEGAJune 23, 2026 · NOC 37769 · Supplement to a New Drug Submission (SNDS)
- RYBREVANT; RYBREVANT SCJune 18, 2026 · NOC 37731 · Supplement to a New Drug Submission (SNDS)
- CONCERTAJune 11, 2026 · NOC 37707 · Supplement to a New Drug Submission (SNDS)
- DARZALEXMay 22, 2026 · NOC 37597 · Supplement to a New Drug Submission (SNDS)
- CARVYKTIMay 13, 2026 · NOC 37529 · Supplement to a New Drug Submission (SNDS)
- SIMPONI; SIMPONI I.V.April 7, 2026 · NOC 37285 · Supplement to a New Drug Submission (SNDS)
- LAZCLUZEMarch 25, 2026 · NOC 37180 · Supplement to a New Drug Submission (SNDS)
- TREMFYAMarch 23, 2026 · NOC 37158 · Supplement to a New Drug Submission (SNDS)
- ERLEADAMarch 19, 2026 · NOC 37156 · Supplement to a New Drug Submission (SNDS)
- INVOKAMETMarch 3, 2026 · NOC 37025 · Supplement to a New Drug Submission (SNDS)
- RYBREVANTJanuary 12, 2026 · NOC 36714 · Supplement to a New Drug Submission (SNDS)
- TREMFYA ONE-PRESSJanuary 6, 2026 · NOC 36740 · Supplement to a New Drug Submission (SNDS)
- BALVERSADecember 18, 2025 · NOC 36603 · Supplement to a New Drug Submission (SNDS)
- VERMOXDecember 11, 2025 · NOC 36530 · Supplement to a New Drug Submission (SNDS)
- IMAAVYDecember 5, 2025 · NOC 36540 · New Drug Submission (NDS)
- IMBRUVICADecember 2, 2025 · NOC 36469 · Supplement to a New Drug Submission (SNDS)
- DARZALEX SCNovember 18, 2025 · NOC 36402 · Supplement to a New Drug Submission (SNDS)
- TREMFYA; TREMFYA ONE-PRESSNovember 17, 2025 · NOC 36386 · Supplement to a New Drug Submission (SNDS)
- LIVMOTYNovember 7, 2025 · NOC 36367 · Supplement to a New Drug Submission (SNDS)
- SIMPONINovember 5, 2025 · NOC 36334 · Supplement to a New Drug Submission (SNDS)
- STELARANovember 5, 2025 · NOC 36335 · Supplement to a New Drug Submission (SNDS)
- FINLIUSNovember 5, 2025 · NOC 36336 · Supplement to a New Drug Submission (SNDS)
- DARZALEX; DARZALEX SCNovember 4, 2025 · NOC 36328 · Supplement to a New Drug Submission (SNDS)
- RYBREVANTNovember 4, 2025 · NOC 36331 · Supplement to a New Drug Submission (SNDS)
- TALVEYOctober 23, 2025 · NOC 36236 · Supplement to a New Drug Submission (SNDS)
- PREZCOBIXOctober 16, 2025 · NOC 36193 · Supplement to a New Drug Submission (SNDS)
- CARVYKTISeptember 24, 2025 · NOC 36055 · Supplement to a New Drug Submission (SNDS)
- OPSUMITSeptember 12, 2025 · NOC 35996 · Supplement to a New Drug Submission (SNDS)
- TRACLEERSeptember 12, 2025 · NOC 35999 · Supplement to a New Drug Submission (SNDS)
- TREMFYA; TREMFYA I.V.; TREMFYA ONE-PRESSSeptember 3, 2025 · NOC 35948 · Supplement to a New Drug Submission (SNDS)
- SIMPONI; SIMPONI I.V.August 7, 2025 · NOC 35804 · Supplement to a New Drug Submission (SNDS)
- TOPAMAXJuly 23, 2025 · NOC 35720 · Supplement to a New Drug Submission (SNDS)
- LIVMOTYJuly 17, 2025 · NOC 35686 · New Drug Submission (NDS)
- RYBREVANTJuly 16, 2025 · NOC 35677 · Supplement to a New Drug Submission (SNDS)
- TREMFYA; TREMFYA I.V.; TREMFYA ONE-PRESSJuly 7, 2025 · NOC 35647 · Supplement to a New Drug Submission (SNDS)
- TECVAYLIJune 26, 2025 · NOC 35597 · Supplement to a New Drug Submission (SNDS)
- SPORANOXJune 4, 2025 · NOC 35479 · Supplement to a New Drug Submission (SNDS)
- SPRAVATOMay 23, 2025 · NOC 35409 · Supplement to a New Drug Submission (SNDS)
- TECVAYLIMay 1, 2025 · NOC 35310 · Supplement to a New Drug Submission (SNDS)
- OMVYENCEApril 8, 2025 · NOC 35162 · Supplement to a New Drug Submission (SNDS)
- OPSYNVIMarch 21, 2025 · NOC 35061 · Supplement to a New Drug Submission (SNDS)
- IMBRUVICAMarch 20, 2025 · NOC 35055 · Supplement to a New Drug Submission (SNDS)
- AKEEGAMarch 12, 2025 · NOC 35012 · Supplement to a New Drug Submission (SNDS)
- LAZCLUZEMarch 6, 2025 · NOC 34959 · New Drug Submission (NDS)
- BALVERSAFebruary 5, 2025 · NOC 34794 · Supplement to a New Drug Submission (SNDS)
- REMICADEJanuary 30, 2025 · NOC 34761 · Supplement to a New Drug Submission (SNDS)
- CARVYKTIJanuary 21, 2025 · NOC 34718 · Supplement to a New Drug Submission (SNDS)
- RYBREVANTJanuary 13, 2025 · NOC 34686 · Supplement to a New Drug Submission (SNDS)
- DARZALEX SCNovember 27, 2024 · NOC 34581 · Supplement to a New Drug Submission (SNDS)
- EDURANTNovember 25, 2024 · NOC 34445 · Supplement to a New Drug Submission (SNDS)
- BALVERSANovember 20, 2024 · NOC 34455 · Supplement to a New Drug Submission (SNDS)
- CARVYKTINovember 8, 2024 · NOC 36568 · Supplement to a New Drug Submission (SNDS)
- FINLIUS; FINLIUS I.V.November 7, 2024 · NOC 34627 · Supplement to a New Drug Submission (SNDS)
- TECVAYLINovember 5, 2024 · NOC 34420 · Supplement to a New Drug Submission (SNDS)
- BALVERSASeptember 25, 2024 · NOC 34232 · Supplement to a New Drug Submission (SNDS)
- CONCERTASeptember 24, 2024 · NOC 34077 · Supplement to a New Drug Submission (SNDS)
- TECVAYLIAugust 29, 2024 · NOC 33903 · Supplement to a New Drug Submission (SNDS)
- TECVAYLIAugust 28, 2024 · NOC 33884 · Supplement to a New Drug Submission (SNDS)
- SPRAVATOAugust 27, 2024 · NOC 33921 · Supplement to a New Drug Submission (SNDS)
- ERLEADAAugust 23, 2024 · NOC 33858 · Supplement to a New Drug Submission (SNDS)
- VERMOXAugust 16, 2024 · NOC 33821 · Supplement to a New Drug Submission (SNDS)
- STELARA; STELARA I.V.August 14, 2024 · NOC 33826 · Supplement to a New Drug Submission (SNDS)
- TECVAYLIJuly 31, 2024 · NOC 33740 · Supplement to a New Drug Submission (SNDS)
- SPRAVATOJuly 30, 2024 · NOC 33734 · Supplement to a New Drug Submission (SNDS)
- TRACLEERJuly 30, 2024 · NOC 33737 · Supplement to a New Drug Submission (SNDS)
- OMVYENCEJuly 25, 2024 · NOC 33717 · Supplement to a New Drug Submission (SNDS)
- CARVYKTIJuly 19, 2024 · NOC 33686 · Supplement to a New Drug Submission (SNDS)
- RYBREVANTJune 28, 2024 · NOC 33535 · Supplement to a New Drug Submission (SNDS)
- OMVYENCEJune 17, 2024 · NOC 33553 · Supplement to a New Drug Submission (SNDS)
- SIMPONI I.V.June 4, 2024 · NOC 33393 · Supplement to a New Drug Submission (SNDS)
- TREMFYA ONE-PRESSMay 17, 2024 · NOC 33247 · Supplement to a New Drug Submission (SNDS)
- CONCERTAMay 1, 2024 · NOC 33160 · Supplement to a New Drug Submission (SNDS)
- DARZALEXApril 30, 2024 · NOC 33147 · Supplement to a New Drug Submission (SNDS)
- TALVEYApril 30, 2024 · NOC 33154 · New Drug Submission (NDS)
- OPSYNVIApril 26, 2024 · NOC 33125 · Supplement to a New Drug Submission (SNDS)
- PONVORYApril 3, 2024 · NOC 33030 · Supplement to a New Drug Submission (SNDS)
- CARIPULMarch 28, 2024 · NOC 32983 · Supplement to a New Drug Submission (SNDS)
- INTELENCEMarch 28, 2024 · NOC 32984 · Supplement to a New Drug Submission (SNDS)
- ERLEADAMarch 27, 2024 · NOC 32961 · Supplement to a New Drug Submission (SNDS)
- REMICADEMarch 26, 2024 · NOC 32967 · Supplement to a New Drug Submission (SNDS)
- INVOKANAMarch 11, 2024 · NOC 32853 · Supplement to a New Drug Submission (SNDS)
- INVOKAMETMarch 6, 2024 · NOC 32828 · Supplement to a New Drug Submission (SNDS)
- BALVERSAFebruary 7, 2024 · NOC 32658 · Supplement to a New Drug Submission (SNDS)
- PREZCOBIXJanuary 23, 2024 · NOC 32589 · Supplement to a New Drug Submission (SNDS)
- TREMFYA; TREMFYA ONE-PRESSJanuary 17, 2024 · NOC 32543 · Supplement to a New Drug Submission (SNDS)
- ERLEADAJanuary 9, 2024 · NOC 32489 · Supplement to a New Drug Submission (SNDS)
- SIMPONI; SIMPONI I.VJanuary 5, 2024 · NOC 32477 · Supplement to a New Drug Submission (SNDS)
- SPORANOXOctober 6, 2023 · NOC 31798 · Supplement to a New Drug Submission (SNDS)
The latest 100 of 441.
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- IMAAVY: Affected lots may contain glass particlesSeptember 21, 2026 · Biologic or vaccine · Product quality · Type II
- IMBRUVICA (ibrutinib) - Risk of Serious and Fatal Cardiac Arrhythmias or Cardiac FailureAugust 29, 2022 · Drugs · New safety information - Product safety
- ELMIRON (pentosan polysulfate sodium) and the Risk of Pigmentary MaculopathyDecember 15, 2020 · Drugs · Product safety
- Invokamet (2020-01-15)January 15, 2020 · Drugs · Product safety · Type III
- DARZALEX (daratumumab) and Hepatitis B Virus ReactivationMarch 25, 2019 · Biologic or vaccine · Product safety
- Remipack (2018-03-28)April 6, 2018 · Medical devices · Medical devices · Type I
- INVOKANA® (canagliflozin) and INVOKAMET® (canagliflozin and metformin) - Risk of Lower Limb AmputationSeptember 6, 2017 · Drugs
- SGLT2 Inhibitors [INVOKANA (canagliflozin), FORXIGA (dapagliflozin), XIGDUO (dapagliflozin/metformin), JARDIANCE (empagliflozin)] - Risk of Diabetic KetoacidosisMay 16, 2016 · Drugs · Product safety
- Forxiga, Invokana: Health Canada begins safety review of diabetes drugs known as SGLT2 inhibitors and risk of ketoacidosisJune 22, 2015 · Drugs · Product safety
- Eprex Product Recall (2015-05-19)May 21, 2015 · Drugs - Biologic or vaccine · Product safety · Type II
- Ortho-Cept Tablets (28 DAY) (2015-04-24)April 27, 2015 · Drugs · Product safety · Type II - Type I
- One lot of Ortho-Cept birth control tablets recalled due to potency issuesApril 22, 2015 · Drugs
- STELARA (ustekinumab) - Risk of Rare Serious Skin Conditions - For Health ProfessionalsNovember 21, 2014 · Biologic or vaccine · Product safety
- STELARA (ustekinumab) - Risk of Rare Serious Skin Conditions - For the PublicNovember 21, 2014 · Biologic or vaccine · Product safety
- REMINYL ER (galantamine hydrobromide) - New Safety Information Regarding the Risk of Serious Skin Reactions - For Health ProfessionalsNovember 18, 2014 · Drugs · Product safety
- REMINYL ER (galantamine hydrobromide) - New Safety Information Regarding the Risk of Serious Skin Reactions - For the PublicNovember 18, 2014 · Drugs · Product safety
- Velcade (2014-08-12)September 2, 2014 · Drugs · Product safety · Type II
- DURAGESIC MAT (fentanyl transdermal system) - Introduction of a Single Ink Colour (Dark Green) on all Strengths of Patches - For the PublicJuly 28, 2014 · Drugs · Product safety
- DURAGESIC MAT (fentanyl transdermal system) - Introduction of a Single Ink Colour (Dark Green) on all Strengths of Patches - For Health ProfessionalsJuly 28, 2014 · Drugs · Product safety
- DURAGESIC MAT (fentanyl transdermal system) - Introduction of a Single Ink Colour (Dark Green) on all Strengths of Patches - Notice to HospitalsJuly 28, 2014 · Drugs · Product safety
- TERAZOL 7 Vaginal Cream 0.4% (terconazole); TERAZOL 3 Dual-Pak - Vaginal Cream 0.8%/Vaginal Ovules 80 mg (terconazole) - Risk of Anaphylaxis and Toxic Epidermal Necrolysis - For Health ProfessionalsJune 9, 2014 · Drugs · Product safety
- TERAZOL 7 Vaginal Cream 0.4% (terconazole); TERAZOL 3 Dual-Pak - Vaginal Cream 0.8%/Vaginal Ovules 80 mg (terconazole) - Risk of Anaphylaxis and Toxic Epidermal Necrolysis - For the PublicJune 9, 2014 · Drugs · Product safety
- Remipack (2013-12-12)February 3, 2014 · Medical devices · Medical devices · Type I
- VELCADE (bortezomib) - Fatal if Given Intrathecally - For Health ProfessionalsJanuary 31, 2012 · Drugs · Product safety
- Doribax (doripenem for injection) - Higher Mortality Rate and a Lower Clinical Cure Rate Observed During a Comparative Clinical Trial - Notice to HospitalsJanuary 31, 2012 · Drugs
- Risperdal Consta (risperidone powder for injectable prolonged-release suspension) – Needle Detachments Associated with the Needle Assembly Used for Gluteal InjectionMay 25, 2010 · Drugs · Medical devices
- Zeftera (ceftobiprole medocaril) for Injection - Discontinuation of Sale - Notice to HospitalsApril 9, 2010 · Drugs
- New Safety Information Regarding Intelence (etravirine) and Severe Skin and Hypersensitivity Reactions - For Health ProfessionalsOctober 19, 2009 · Drugs
- Association of Prezista (darunavir) with hepatotoxicity - For Health ProfessionalsMay 15, 2008 · Drugs
- Archived - Association of PREZISTA (darunavir) with hepatotoxicityMay 15, 2008 · Drugs
- Important safety information on Duragesic (fentanyl transdermal system) - For Health Professionals - Janssen-Ortho Inc. - For Health ProfessionalsSeptember 13, 2005 · Drugs
- Archived – Medication Errors Involving Reminyl and Amaryl – Janssen-Ortho Inc. and Aventis Pharma Inc.December 21, 2004 · Drugs · Product safety
- Archived – Medication Errors Involving REMINYL and AMARYL® – Janssen-Ortho Inc. and Aventis Pharma Inc.December 21, 2004 · Drugs · Product safety
- Archived – Medication Errors Involving Reminyl and Amaryl –Janssen-Ortho Inc. and Aventis Pharma Inc.December 21, 2004 · Drugs · Product safety
- Archived – Association of EPREX (Epoetin Alfa) with Thrombotic Vascular Events – Janssen-Ortho Inc. – For the PublicOctober 18, 2004 · Biologic or vaccine · Product safety
- Archived – Association of EPREX (Epoetin Alfa) with Thrombotic Vascular Events – Janssen-Ortho Inc.October 14, 2004 · Biologic or vaccine · Product safety
- Archived – TOPAMAX (topiramate) Use is Associated with Metabolic AcidosisJanuary 21, 2004 · Drugs · Product safety
- Archived – Important Information – Topamax (topiramate) – Janssen Othro Inc.July 17, 2003 · Health products · Product safety
- Archived – EPREX (Epoetin Alfa) – Pure Red Cell Aplasia (PRCA, Erythroblastopenia)June 25, 2002 · Drugs · Product safety
- Archived - Important Safety Information - EPREX (epoetin alfa) - Janssen-Ortho Inc.November 26, 2001 · Biologic or vaccine
- Archived – Association of TOPAMAX* (Topiramate) with Acute Myopia and Secondary Angle Closure GlaucomaSeptember 13, 2001 · Drugs · Product safety